171 related articles for article (PubMed ID: 3402524)
1. Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration.
van Harten J; van Brummelen P; Wilson JH; Lodewijks MT; Breimer DD
Eur J Clin Pharmacol; 1988; 34(4):387-94. PubMed ID: 3402524
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine.
van Harten J; van Brummelen P; Lodewijks MT; Danhof M; Breimer DD
Clin Pharmacol Ther; 1988 Mar; 43(3):332-41. PubMed ID: 3345623
[TBL] [Abstract][Full Text] [Related]
3. Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
van Harten J; Burggraaf J; van Brummelen P; Breimer DD
Clin Pharmacokinet; 1989 Jan; 16(1):55-64. PubMed ID: 2706880
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and hemodynamic effects of long-term nisoldipine treatment in hypertensive patients.
van Harten J; van Brummelen P; Danhof M; Quekel RP; Breimer DD
J Cardiovasc Pharmacol; 1989 Apr; 13(4):624-9. PubMed ID: 2471001
[TBL] [Abstract][Full Text] [Related]
5. Variability in the pharmacokinetics of nisoldipine as caused by differences in liver blood flow response.
van Harten J; van Brummelen P; Ooms P; Danhof M; Blauw GJ; Breimer DD
J Clin Pharmacol; 1989 Aug; 29(8):714-21. PubMed ID: 2778091
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration.
Kleinbloesem CH; van Harten J; Wilson JP; Danhof M; van Brummelen P; Breimer DD
Clin Pharmacol Ther; 1986 Jul; 40(1):21-8. PubMed ID: 3720176
[TBL] [Abstract][Full Text] [Related]
7. The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
van Harten J; van Brummelen P; Zeegers RR; Danhof M; Breimer DD
Br J Clin Pharmacol; 1988 Jun; 25(6):709-17. PubMed ID: 3203043
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of nisoldipine in renal dysfunction.
Boelaert J; Valcke Y; Dammekens H; De Vriese G; Ahr G; Schurgers M; Daneels R; Bogaert MG
Eur J Clin Pharmacol; 1988; 34(2):207-9. PubMed ID: 3383992
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
Karasawa A; Kubo K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
[TBL] [Abstract][Full Text] [Related]
10. Single- and multiple-dose nisoldipine kinetics and effects in the young, the middle-aged, and the elderly.
van Harten J; Burggraaf J; Ligthart GJ; van Brummelen P; Breimer DD
Clin Pharmacol Ther; 1989 Jun; 45(6):600-7. PubMed ID: 2731403
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs.
Ahr HJ; Krause HP; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1099-104. PubMed ID: 3196403
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
13. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.
Pasanisi F; Meredith PA; Reid JL
Eur J Clin Pharmacol; 1985; 29(1):21-4. PubMed ID: 4054203
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentration-response relationships for some cardiovascular effects of dihydropyridines in healthy subjects.
Graefe KH; Ziegler R; Wingender W; Rämsch KD; Schmitz H
Clin Pharmacol Ther; 1988 Jan; 43(1):16-22. PubMed ID: 3335117
[TBL] [Abstract][Full Text] [Related]
15. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition.
Abernethy DR; Gutkowska J; Winterbottom LM
Clin Pharmacol Ther; 1990 Jul; 48(1):76-86. PubMed ID: 2142447
[TBL] [Abstract][Full Text] [Related]
16. [Antianginal effect of calcium antagonists, using nisoldipine as an example].
Hess OM; Krayenbühl HP
Schweiz Med Wochenschr; 1984 Aug; 114(33):1126-31. PubMed ID: 6484542
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].
Schrör K; Latta G; Darius H; Klaus W; Ziegler R
Klin Wochenschr; 1985 Jan; 63(1):16-9. PubMed ID: 3838352
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
Takata Y; Kato H
Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form.
Schaefer HG; Heinig R; Ahr G; Adelmann H; Tetzloff W; Kuhlmann J
Eur J Clin Pharmacol; 1997; 51(6):473-80. PubMed ID: 9112062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
